Drug Shortage Report for MINT-SPIRONOLACTONE
| Report ID | 262196 |
| Drug Identification Number | 02488159 |
| Brand name | MINT-SPIRONOLACTONE |
| Common or Proper name | Spironolactone |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SPIRONOLACTONE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 count bottle |
| ATC code | C03DA |
| ATC description | POTASSIUM-SPARING AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-07-08 |
| Estimated end date | 2026-02-28 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2025-12-04 | French | Compare |
| v11 | 2025-12-04 | English | Compare |
| v10 | 2025-10-31 | French | Compare |
| v9 | 2025-10-31 | English | Compare |
| v8 | 2025-09-16 | French | Compare |
| v7 | 2025-09-16 | English | Compare |
| v6 | 2025-08-29 | French | Compare |
| v5 | 2025-08-29 | English | Compare |
| v4 | 2025-07-17 | English | Compare |
| v3 | 2025-07-09 | English | Compare |
| v2 | 2025-07-08 | French | Compare |
| v1 | 2025-07-08 | English | Compare |
Showing 1 to 12 of 12